Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proof of Concept Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04735757
What this trial is testing

Effects of COVID-19 Infection and Critical Illness on Diaphragm Tissue Characteristics and Movement, Visualized With MRI

Who this might be right for
Diaphragm DiseaseCovid19
Amsterdam UMC, location VUmc 40
Not applicableStudy completedNCT06813066
What this trial is testing

Simulating Psychotherapeutic Sessions With Generative Artificial Intelligence

Who this might be right for
Mental Disorder
University Hospital, Basel, Switzerland 520
Testing effectiveness (Phase 2)Study completedNCT00496236
What this trial is testing

Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Neoplasms
GenVec
Testing effectiveness (Phase 2)Study completedNCT01594281
What this trial is testing

Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)

Who this might be right for
Proliferative Diabetic Retinopathy (PDR)
Novartis Pharmaceuticals 107
Testing effectiveness (Phase 2)Study completedNCT04991753
What this trial is testing

A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Janssen Research & Development, LLC 53
Testing effectiveness (Phase 2)Study completedNCT03333928
What this trial is testing

A POC and Dose-Ranging Study of HTD1801 in PSC Patients

Who this might be right for
Primary Sclerosing Cholangitis (PSC)
HighTide Therapeutics (Hong Kong) Limited 59
Testing effectiveness (Phase 2)Ended earlyNCT00107666
What this trial is testing

CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)

Who this might be right for
Coronary DiseaseHeart Valve Diseases
Critical Therapeutics 150
Post-approval studies (Phase 4)Active Not RecruitingNCT03968822
What this trial is testing

Intralipid® 20% for Reversal of Local Anesthetics

Who this might be right for
Anesthesia, Local
Hospital for Special Surgery, New York 18
Testing effectiveness (Phase 2)Study completedNCT05040698
What this trial is testing

Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
Holdsworth House Medical Practice 20
Testing effectiveness (Phase 2)UnknownNCT06315608
What this trial is testing

MRG-001 in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisLou Gehrig DiseaseMotor Neuron Disease+1 more
MedRegen LLC 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07671248
What this trial is testing

Tirzepatide in the Treatment of Cannabis Use Disorder

Who this might be right for
Cannabis Use Disorder, ModerateCannabis Use Disorder, Severe
McMaster University 15
Testing effectiveness (Phase 2)WithdrawnNCT01666704
What this trial is testing

Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis

Who this might be right for
Atherosclerotic Cardiovascular Disease
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT03837743
What this trial is testing

Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Durect 25
Post-approval studies (Phase 4)UnknownNCT02059772
What this trial is testing

Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
GWT-TUD GmbH 25
Testing effectiveness (Phase 2)Ended earlyNCT01813019
What this trial is testing

Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy

Who this might be right for
Patient Diagnosed With OCD and Resistant to SSRI TreatmentFailed SSRI Over 12 Weeks at Appropriate Doses
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT02614872
What this trial is testing

Study to Evaluate the Safety and Efficacy of Intravenous Glassia® Treatment in Lung Transplantation

Who this might be right for
Transplantation, Lung Rejection
Kamada, Ltd. 30
Not applicableStudy completedNCT02857972
What this trial is testing

Proof Of Concept Menstrual Hygiene Product-Wondaleaf®

Who this might be right for
Other Menstruation Disorders
Clinical Research Centre, Malaysia 36
Not applicableStudy completedNCT06064266
What this trial is testing

Healthy Fat, Happy Microbiome (TAPIR), Proof-of-Concept Study

Who this might be right for
Small Intestine
Wageningen University 16
Testing effectiveness (Phase 2)Study completedNCT01116895
What this trial is testing

A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 63
Not applicableStudy completedNCT03302026
What this trial is testing

Real Time fMRI and Quitting Smoking

Who this might be right for
Nicotine Use Disorder
University of Pennsylvania 46
Next Page